WIN-Partners Co., Ltd. (TYO:3183)

Japan flag Japan · Delayed Price · Currency is JPY
1,563.00
+44.00 (2.90%)
Mar 14, 2025, 3:30 PM JST
25.44%
Market Cap 42.23B
Revenue (ttm) 82.61B
Net Income (ttm) 2.05B
Shares Out 28.86M
EPS (ttm) 71.56
PE Ratio 20.44
Forward PE n/a
Dividend 51.00 (3.26%)
Ex-Dividend Date Mar 28, 2025
Volume 103,400
Average Volume 70,960
Open 1,524.00
Previous Close 1,519.00
Day's Range 1,515.00 - 1,568.00
52-Week Range 1,012.00 - 1,568.00
Beta 0.08
RSI 83.01
Earnings Date May 15, 2025

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic ... [Read more]

Sector Healthcare
Founded 1973
Employees 629
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 3183
Full Company Profile

Financial Performance

In 2023, WIN-Partners's revenue was 77.06 billion, an increase of 8.76% compared to the previous year's 70.85 billion. Earnings were 1.84 billion, a decrease of -10.36%.

Financial Statements

News

There is no news available yet.